世界および日本のインフルエンザウイルスワクチン(H1N1)市場の洞察、2027年までの予測Global and Japan Influenza Virus Vaccine (H1N1) Market Insights, Forecast to 2027 インフルエンザウイルスワクチン(H1N1)は、以前は豚インフルエンザとして知られていたa(H1N1)ウイルスを防御するために特別に設計されています。 市場分析と洞察。世界と日本のインフルエンザウイルスワク... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリーインフルエンザウイルスワクチン(H1N1)は、以前は豚インフルエンザとして知られていたa(H1N1)ウイルスを防御するために特別に設計されています。市場分析と洞察。世界と日本のインフルエンザウイルスワクチン(H1N1)市場 本レポートでは、世界と日本のインフルエンザウイルスワクチン(H1N1)市場に焦点を当てています。 2020年のインフルエンザウイルスワクチン(H1N1)の世界市場規模はXX百万米ドルで、2021年から2027年の間にXX%のCAGRで、2027年末にはXX百万米ドルに達すると予想されています。日本では、インフルエンザウイルスワクチン(H1N1)の市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX%のCAGRで成長すると予想されています。 世界のインフルエンザウイルスワクチン(H1N1)の範囲と市場規模 インフルエンザウイルスワクチン(H1N1)市場は、地域(国)別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のインフルエンザウイルスワクチン(H1N1)市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、地域(国)別、タイプ別、アプリケーション別の収益と予測に焦点を当て、2016年から2027年の期間で収益と予測を示しています。 日本市場では、2016-2027年のインフルエンザウイルスワクチン(H1N1)の市場規模を、プレイヤー別、タイプ別、アプリケーション別に分析しています。主要プレイヤーには、日本で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。 タイプ別セグメント 筋注用ワクチン 鼻腔内投与ワクチン 用途別セグメント 3歳から10歳まで 10歳以上18歳未満 18歳以上 その他 地域別 北アメリカ U.S. カナダ ヨーロッパ ドイツ フランス イギリス イタリア ロシア アジアパシフィック 中国 日本 韓国 インド オーストラリア 台湾 インドネシア タイ マレーシア フィリピン ベトナム ラテンアメリカ メキシコ ブラジル アルゼンチン 中近東・アフリカ トルコ サウジアラビア UAE 会社別 CSL NVS(ノバルティス) サノフィパスツール(Sanofi Pasteur) メディミューン GSK バクスター 北京克星バイオワクチン 華蘭バイオワクチン(Hualan Bio-Vaccine 長春長生生物技術有限公司(Changchun Changsheng Bio-Technology 北京天壇生物製品有限公司 江蘇ヤンセン・バイオテクノロジー 浙江天元バイオ製薬 大連亜里峰バイオ製薬 シノファーム 目次1 Study Coverage1.1 Influenza Virus Vaccine (H1N1) Product Introduction 1.2 Market by Type 1.2.1 Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Type 1.2.2 Intramuscular Vaccine 1.2.3 Nasal Spray Vaccine 1.3 Market by Application 1.3.1 Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Application 1.3.2 3 To 10 Years Old 1.3.3 10 To 18 Years Old 1.3.4 Above 18 Years Old 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Influenza Virus Vaccine (H1N1) Market Size, Estimates and Forecasts 2.1.1 Global Influenza Virus Vaccine (H1N1) Revenue 2016-2027 2.1.2 Global Influenza Virus Vaccine (H1N1) Sales 2016-2027 2.2 Global Influenza Virus Vaccine (H1N1), Market Size by Region: 2016 VS 2021 VS 2027 2.3 Influenza Virus Vaccine (H1N1) Historical Market Size by Region (2016-2021) 2.3.1 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2022-2027) 2.4.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2022-2027) 3 Global Influenza Virus Vaccine (H1N1) Competitor Landscape by Players 3.1 Global Top Influenza Virus Vaccine (H1N1) Manufacturers by Sales 3.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Manufacturer (2016-2021) 3.1.2 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Influenza Virus Vaccine (H1N1) Manufacturers by Revenue 3.2.1 Key Influenza Virus Vaccine (H1N1) Manufacturers Covered: Ranking by Revenue 3.2.2 Global Influenza Virus Vaccine (H1N1) Revenue by Manufacturers (2016-2021) 3.2.3 Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Influenza Virus Vaccine (H1N1) Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Influenza Virus Vaccine (H1N1) Revenue in 2020 3.2.6 Global Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Influenza Virus Vaccine (H1N1) Price by Manufacturers 3.4 Global Influenza Virus Vaccine (H1N1) Manufacturing Base Distribution, Product Types 3.4.1 Influenza Virus Vaccine (H1N1) Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Influenza Virus Vaccine (H1N1) Product Type 3.4.3 Date of International Manufacturers Enter into Influenza Virus Vaccine (H1N1) Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) 4.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) 4.1.2 Global Influenza Virus Vaccine (H1N1) Revenue by Type (2016-2021) 4.1.3 Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Type (2022-2027) 4.2.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2022-2027) 4.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2022-2027) 4.2.3 Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) 5.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) 5.1.2 Global Influenza Virus Vaccine (H1N1) Revenue by Application (2016-2021) 5.1.3 Influenza Virus Vaccine (H1N1) Price by Application (2016-2021) 5.2 Influenza Virus Vaccine (H1N1) Market Size Forecast by Application (2022-2027) 5.2.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2022-2027) 5.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2022-2027) 5.2.3 Global Influenza Virus Vaccine (H1N1) Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027 6.1.1 Japan Influenza Virus Vaccine (H1N1) Sales YoY Growth 2016-2027 6.1.2 Japan Influenza Virus Vaccine (H1N1) Revenue YoY Growth 2016-2027 6.1.3 Japan Influenza Virus Vaccine (H1N1) Market Share in Global Market 2016-2027 6.2 Japan Influenza Virus Vaccine (H1N1) Market Size by Players (International and Local Players) 6.2.1 Japan Top Influenza Virus Vaccine (H1N1) Players by Sales (2016-2021) 6.2.2 Japan Top Influenza Virus Vaccine (H1N1) Players by Revenue (2016-2021) 6.3 Japan Influenza Virus Vaccine (H1N1) Historic Market Review by Type (2016-2021) 6.3.1 Japan Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2021) 6.3.2 Japan Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2016-2021) 6.3.3 Japan Influenza Virus Vaccine (H1N1) Price by Type (2016-2021) 6.4 Japan Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2022-2027) 6.4.2 Japan Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2022-2027) 6.4.3 Japan Influenza Virus Vaccine (H1N1) Price Forecast by Type (2022-2027) 6.5 Japan Influenza Virus Vaccine (H1N1) Historic Market Review by Application (2016-2021) 6.5.1 Japan Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2021) 6.5.2 Japan Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2016-2021) 6.5.3 Japan Influenza Virus Vaccine (H1N1) Price by Application (2016-2021) 6.6 Japan Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2022-2027) 6.6.2 Japan Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2022-2027) 6.6.3 Japan Influenza Virus Vaccine (H1N1) Price Forecast by Application (2022-2027) 7 North America 7.1 North America Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027 7.2 North America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country 7.2.1 North America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) 7.2.2 North America Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027 8.2 Asia Pacific Influenza Virus Vaccine (H1N1) Market Facts & Figures by Region 8.2.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021) 8.2.2 Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027 9.2 Europe Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country 9.2.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) 9.2.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027 10.2 Latin America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country 10.2.1 Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) 10.2.2 Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country 11.2.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) 11.2.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 CSL 12.1.1 CSL Corporation Information 12.1.2 CSL Description and Business Overview 12.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.1.4 CSL Influenza Virus Vaccine (H1N1) Products Offered 12.1.5 CSL Recent Development 12.2 NVS(Novartis) 12.2.1 NVS(Novartis) Corporation Information 12.2.2 NVS(Novartis) Description and Business Overview 12.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.2.4 NVS(Novartis) Influenza Virus Vaccine (H1N1) Products Offered 12.2.5 NVS(Novartis) Recent Development 12.3 Sanofi Pasteur 12.3.1 Sanofi Pasteur Corporation Information 12.3.2 Sanofi Pasteur Description and Business Overview 12.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Products Offered 12.3.5 Sanofi Pasteur Recent Development 12.4 Medimmune 12.4.1 Medimmune Corporation Information 12.4.2 Medimmune Description and Business Overview 12.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Medimmune Influenza Virus Vaccine (H1N1) Products Offered 12.4.5 Medimmune Recent Development 12.5 GSK 12.5.1 GSK Corporation Information 12.5.2 GSK Description and Business Overview 12.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.5.4 GSK Influenza Virus Vaccine (H1N1) Products Offered 12.5.5 GSK Recent Development 12.6 Baxter 12.6.1 Baxter Corporation Information 12.6.2 Baxter Description and Business Overview 12.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Baxter Influenza Virus Vaccine (H1N1) Products Offered 12.6.5 Baxter Recent Development 12.7 Beijing Kexing Bio-Vaccine 12.7.1 Beijing Kexing Bio-Vaccine Corporation Information 12.7.2 Beijing Kexing Bio-Vaccine Description and Business Overview 12.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered 12.7.5 Beijing Kexing Bio-Vaccine Recent Development 12.8 Hualan Bio-Vaccine 12.8.1 Hualan Bio-Vaccine Corporation Information 12.8.2 Hualan Bio-Vaccine Description and Business Overview 12.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered 12.8.5 Hualan Bio-Vaccine Recent Development 12.9 Changchun Changsheng Bio-Technology 12.9.1 Changchun Changsheng Bio-Technology Corporation Information 12.9.2 Changchun Changsheng Bio-Technology Description and Business Overview 12.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Products Offered 12.9.5 Changchun Changsheng Bio-Technology Recent Development 12.10 Beijing Tiantan Bio-Products 12.10.1 Beijing Tiantan Bio-Products Corporation Information 12.10.2 Beijing Tiantan Bio-Products Description and Business Overview 12.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Products Offered 12.10.5 Beijing Tiantan Bio-Products Recent Development 12.11 CSL 12.11.1 CSL Corporation Information 12.11.2 CSL Description and Business Overview 12.11.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.11.4 CSL Influenza Virus Vaccine (H1N1) Products Offered 12.11.5 CSL Recent Development 12.12 Zhejiang Tianyuan Bio-Pharmaceutical 12.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information 12.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Description and Business Overview 12.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Products Offered 12.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Development 12.13 Dalian Yalifeng Bio-Pharmaceutical 12.13.1 Dalian Yalifeng Bio-Pharmaceutical Corporation Information 12.13.2 Dalian Yalifeng Bio-Pharmaceutical Description and Business Overview 12.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Dalian Yalifeng Bio-Pharmaceutical Products Offered 12.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Development 12.14 Sinopharm 12.14.1 Sinopharm Corporation Information 12.14.2 Sinopharm Description and Business Overview 12.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Sinopharm Products Offered 12.14.5 Sinopharm Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Influenza Virus Vaccine (H1N1) Industry Trends 13.2 Influenza Virus Vaccine (H1N1) Market Drivers 13.3 Influenza Virus Vaccine (H1N1) Market Challenges 13.4 Influenza Virus Vaccine (H1N1) Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Influenza Virus Vaccine (H1N1) Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
SummaryInfluenza Virus Vaccine (H1N1), which is specifically designed to protect against the a (H1N1) virus, previously known as swine flu. Table of Contents1 Study Coverage1.1 Influenza Virus Vaccine (H1N1) Product Introduction 1.2 Market by Type 1.2.1 Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Type 1.2.2 Intramuscular Vaccine 1.2.3 Nasal Spray Vaccine 1.3 Market by Application 1.3.1 Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Application 1.3.2 3 To 10 Years Old 1.3.3 10 To 18 Years Old 1.3.4 Above 18 Years Old 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Influenza Virus Vaccine (H1N1) Market Size, Estimates and Forecasts 2.1.1 Global Influenza Virus Vaccine (H1N1) Revenue 2016-2027 2.1.2 Global Influenza Virus Vaccine (H1N1) Sales 2016-2027 2.2 Global Influenza Virus Vaccine (H1N1), Market Size by Region: 2016 VS 2021 VS 2027 2.3 Influenza Virus Vaccine (H1N1) Historical Market Size by Region (2016-2021) 2.3.1 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2022-2027) 2.4.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2022-2027) 3 Global Influenza Virus Vaccine (H1N1) Competitor Landscape by Players 3.1 Global Top Influenza Virus Vaccine (H1N1) Manufacturers by Sales 3.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Manufacturer (2016-2021) 3.1.2 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Influenza Virus Vaccine (H1N1) Manufacturers by Revenue 3.2.1 Key Influenza Virus Vaccine (H1N1) Manufacturers Covered: Ranking by Revenue 3.2.2 Global Influenza Virus Vaccine (H1N1) Revenue by Manufacturers (2016-2021) 3.2.3 Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Influenza Virus Vaccine (H1N1) Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Influenza Virus Vaccine (H1N1) Revenue in 2020 3.2.6 Global Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Influenza Virus Vaccine (H1N1) Price by Manufacturers 3.4 Global Influenza Virus Vaccine (H1N1) Manufacturing Base Distribution, Product Types 3.4.1 Influenza Virus Vaccine (H1N1) Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Influenza Virus Vaccine (H1N1) Product Type 3.4.3 Date of International Manufacturers Enter into Influenza Virus Vaccine (H1N1) Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) 4.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) 4.1.2 Global Influenza Virus Vaccine (H1N1) Revenue by Type (2016-2021) 4.1.3 Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Type (2022-2027) 4.2.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2022-2027) 4.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2022-2027) 4.2.3 Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) 5.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) 5.1.2 Global Influenza Virus Vaccine (H1N1) Revenue by Application (2016-2021) 5.1.3 Influenza Virus Vaccine (H1N1) Price by Application (2016-2021) 5.2 Influenza Virus Vaccine (H1N1) Market Size Forecast by Application (2022-2027) 5.2.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2022-2027) 5.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2022-2027) 5.2.3 Global Influenza Virus Vaccine (H1N1) Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027 6.1.1 Japan Influenza Virus Vaccine (H1N1) Sales YoY Growth 2016-2027 6.1.2 Japan Influenza Virus Vaccine (H1N1) Revenue YoY Growth 2016-2027 6.1.3 Japan Influenza Virus Vaccine (H1N1) Market Share in Global Market 2016-2027 6.2 Japan Influenza Virus Vaccine (H1N1) Market Size by Players (International and Local Players) 6.2.1 Japan Top Influenza Virus Vaccine (H1N1) Players by Sales (2016-2021) 6.2.2 Japan Top Influenza Virus Vaccine (H1N1) Players by Revenue (2016-2021) 6.3 Japan Influenza Virus Vaccine (H1N1) Historic Market Review by Type (2016-2021) 6.3.1 Japan Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2021) 6.3.2 Japan Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2016-2021) 6.3.3 Japan Influenza Virus Vaccine (H1N1) Price by Type (2016-2021) 6.4 Japan Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2022-2027) 6.4.2 Japan Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2022-2027) 6.4.3 Japan Influenza Virus Vaccine (H1N1) Price Forecast by Type (2022-2027) 6.5 Japan Influenza Virus Vaccine (H1N1) Historic Market Review by Application (2016-2021) 6.5.1 Japan Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2021) 6.5.2 Japan Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2016-2021) 6.5.3 Japan Influenza Virus Vaccine (H1N1) Price by Application (2016-2021) 6.6 Japan Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2022-2027) 6.6.2 Japan Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2022-2027) 6.6.3 Japan Influenza Virus Vaccine (H1N1) Price Forecast by Application (2022-2027) 7 North America 7.1 North America Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027 7.2 North America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country 7.2.1 North America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) 7.2.2 North America Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027 8.2 Asia Pacific Influenza Virus Vaccine (H1N1) Market Facts & Figures by Region 8.2.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021) 8.2.2 Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027 9.2 Europe Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country 9.2.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) 9.2.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027 10.2 Latin America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country 10.2.1 Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) 10.2.2 Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country 11.2.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) 11.2.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 CSL 12.1.1 CSL Corporation Information 12.1.2 CSL Description and Business Overview 12.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.1.4 CSL Influenza Virus Vaccine (H1N1) Products Offered 12.1.5 CSL Recent Development 12.2 NVS(Novartis) 12.2.1 NVS(Novartis) Corporation Information 12.2.2 NVS(Novartis) Description and Business Overview 12.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.2.4 NVS(Novartis) Influenza Virus Vaccine (H1N1) Products Offered 12.2.5 NVS(Novartis) Recent Development 12.3 Sanofi Pasteur 12.3.1 Sanofi Pasteur Corporation Information 12.3.2 Sanofi Pasteur Description and Business Overview 12.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Products Offered 12.3.5 Sanofi Pasteur Recent Development 12.4 Medimmune 12.4.1 Medimmune Corporation Information 12.4.2 Medimmune Description and Business Overview 12.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Medimmune Influenza Virus Vaccine (H1N1) Products Offered 12.4.5 Medimmune Recent Development 12.5 GSK 12.5.1 GSK Corporation Information 12.5.2 GSK Description and Business Overview 12.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.5.4 GSK Influenza Virus Vaccine (H1N1) Products Offered 12.5.5 GSK Recent Development 12.6 Baxter 12.6.1 Baxter Corporation Information 12.6.2 Baxter Description and Business Overview 12.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Baxter Influenza Virus Vaccine (H1N1) Products Offered 12.6.5 Baxter Recent Development 12.7 Beijing Kexing Bio-Vaccine 12.7.1 Beijing Kexing Bio-Vaccine Corporation Information 12.7.2 Beijing Kexing Bio-Vaccine Description and Business Overview 12.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered 12.7.5 Beijing Kexing Bio-Vaccine Recent Development 12.8 Hualan Bio-Vaccine 12.8.1 Hualan Bio-Vaccine Corporation Information 12.8.2 Hualan Bio-Vaccine Description and Business Overview 12.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered 12.8.5 Hualan Bio-Vaccine Recent Development 12.9 Changchun Changsheng Bio-Technology 12.9.1 Changchun Changsheng Bio-Technology Corporation Information 12.9.2 Changchun Changsheng Bio-Technology Description and Business Overview 12.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Products Offered 12.9.5 Changchun Changsheng Bio-Technology Recent Development 12.10 Beijing Tiantan Bio-Products 12.10.1 Beijing Tiantan Bio-Products Corporation Information 12.10.2 Beijing Tiantan Bio-Products Description and Business Overview 12.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Products Offered 12.10.5 Beijing Tiantan Bio-Products Recent Development 12.11 CSL 12.11.1 CSL Corporation Information 12.11.2 CSL Description and Business Overview 12.11.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.11.4 CSL Influenza Virus Vaccine (H1N1) Products Offered 12.11.5 CSL Recent Development 12.12 Zhejiang Tianyuan Bio-Pharmaceutical 12.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information 12.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Description and Business Overview 12.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Products Offered 12.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Development 12.13 Dalian Yalifeng Bio-Pharmaceutical 12.13.1 Dalian Yalifeng Bio-Pharmaceutical Corporation Information 12.13.2 Dalian Yalifeng Bio-Pharmaceutical Description and Business Overview 12.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Dalian Yalifeng Bio-Pharmaceutical Products Offered 12.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Development 12.14 Sinopharm 12.14.1 Sinopharm Corporation Information 12.14.2 Sinopharm Description and Business Overview 12.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Sinopharm Products Offered 12.14.5 Sinopharm Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Influenza Virus Vaccine (H1N1) Industry Trends 13.2 Influenza Virus Vaccine (H1N1) Market Drivers 13.3 Influenza Virus Vaccine (H1N1) Market Challenges 13.4 Influenza Virus Vaccine (H1N1) Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Influenza Virus Vaccine (H1N1) Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(抗生物薬)の最新刊レポート
QYResearch社の抗生物薬分野での最新刊レポート
本レポートと同じKEY WORD(vaccine)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |